Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. The firm's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company sells its products to veterinarians, distributors, animal producers, farmers and pet owners.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
65,011
65,011
64,168
60,115
59,283
48,704
Revenue Growth (YoY)
1%
1%
7%
1%
22%
17%
Cost of Revenue
13,947
12,027
14,698
15,915
17,206
13,241
Gross Profit
51,064
52,984
49,470
44,200
42,077
35,463
Selling, General & Admin
10,681
10,610
10,733
10,382
9,948
9,615
Research & Development
15,609
15,595
14,442
12,663
11,818
10,254
Operating Expenses
26,290
26,205
25,175
23,045
21,766
19,869
Other Non Operating Income (Expenses)
1,024
509
1,093
917
960
468
Pretax Income
21,067
21,067
19,936
1,889
16,444
13,879
Income Tax Expense
2,805
2,804
2,803
1,512
1,918
1,521
Net Income
18,254
18,254
17,117
365
14,519
13,049
Net Income Growth
7%
7%
4,590%
-97%
11%
85%
Shares Outstanding (Diluted)
2,488
2,507
2,541
2,547
2,542
2,538
Shares Change (YoY)
-2%
-1%
0%
0%
0%
0%
EPS (Diluted)
7.33
7.28
6.74
0.14
5.71
5.14
EPS Growth
9%
8%
4,714%
-98%
11%
85%
Free Cash Flow
12,360
12,360
18,096
9,143
14,707
9,661
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
78.54%
81.5%
77.09%
73.52%
70.97%
72.81%
Operating Margin
38.1%
41.19%
37.86%
35.19%
34.26%
32.01%
Profit Margin
28.07%
28.07%
26.67%
0.6%
24.49%
26.79%
Free Cash Flow Margin
19.01%
19.01%
28.2%
15.2%
24.8%
19.83%
EBITDA
30,612
32,617
28,794
25,027
24,220
18,808
EBITDA Margin
47.08%
50.17%
44.87%
41.63%
40.85%
38.61%
D&A For EBITDA
5,838
5,838
4,499
3,872
3,909
3,214
EBIT
24,774
26,779
24,295
21,155
20,311
15,594
EBIT Margin
38.1%
41.19%
37.86%
35.19%
34.26%
32.01%
Effective Tax Rate
13.31%
13.3%
14.05%
80.04%
11.66%
10.95%
Follow-Up Questions
What are Merck & Co Inc's key financial statements?
According to the latest financial statement (Form-10K), Merck & Co Inc has a total asset of $136,866, Net profit of $18,254
What are the key financial ratios for MRK?
Merck & Co Inc's Current ratio is 1.62, has a Net margin is 28.07, sales per share of $25.93.
How is Merck & Co Inc's revenue broken down by segment or geography?
Merck & Co Inc largest revenue segment is Pharmaceutical, at a revenue of 58,142,000,000 in the most earnings release.For geography, United States is the primary market for Merck & Co Inc, at a revenue of 36,510,000,000.
Is Merck & Co Inc profitable?
yes, according to the latest financial statements, Merck & Co Inc has a net profit of $18,254
Does Merck & Co Inc have any liabilities?
yes, Merck & Co Inc has liability of 84,260
How many outstanding shares for Merck & Co Inc?
Merck & Co Inc has a total outstanding shares of 2,474.62